Lal Brajesh K
Division of Vascular Surgery, UMDNJ-New Jersey Medical School, Newark, NJ 07103, USA.
Semin Vasc Surg. 2007 Dec;20(4):259-66. doi: 10.1053/j.semvascsurg.2007.10.009.
Carotid endarterectomy (CEA) is the preferred method for cerebral revascularization in patients with symptomatic and asymptomatic high-grade extracranial carotid artery stenosis. Carotid artery stenting (CAS) has recently emerged as a less invasive alternative to endarterectomy. Carotid stenting has been demonstrated to be technically feasible and safe in high-risk patients. It has been approved as an acceptable method for revascularization in circumstances where CEA yields suboptimal results. While the final role of CAS in carotid revascularization will be determined on the basis of ongoing randomized trials, it is clear that stenting will continue to be performed in subgroups of patients with carotid stenosis. Therefore, it is anticipated that there will be a corresponding increase in the number of in-stent restenosis cases. Considerable controversy exists regarding the clinical significance, natural history, threshold for management, and appropriate intervention of recurrent carotid stenosis after endarterectomy and after stenting. This review analyzes current information on this important clinical problem and presents evidence-based recommendations for the diagnosis and management of recurrent carotid stenosis.
颈动脉内膜切除术(CEA)是有症状和无症状的重度颅外颈动脉狭窄患者进行脑血运重建的首选方法。颈动脉支架置入术(CAS)最近已成为一种比内膜切除术侵入性更小的替代方法。颈动脉支架置入术已被证明在高危患者中技术上可行且安全。在CEA效果欠佳的情况下,它已被批准为一种可接受的血运重建方法。虽然CAS在颈动脉血运重建中的最终作用将根据正在进行的随机试验来确定,但很明显,支架置入术将继续在颈动脉狭窄患者亚组中进行。因此,预计支架内再狭窄病例数量将相应增加。关于内膜切除术后和支架置入术后复发性颈动脉狭窄的临床意义、自然病程、处理阈值和适当干预存在相当大的争议。本综述分析了关于这一重要临床问题的当前信息,并提出了基于证据的复发性颈动脉狭窄诊断和管理建议。